Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prevalence of bile acid diarrhea and effect of budesonide on bile acid homeostasis in microscopic colitis
2019-002762-12Phase 4Completed
- Sponsor
- Zealand University Hospital
- Start
- Jul 2019
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, single-arm trial of budesonide in microscopic colitis (MC) and bile acid diarrhea (BAD), sponsored by Zealand University Hospital. Primary endpoint: Prevalence of bile acid diarrhea by serum C4. Started Jul 2019; status: completed.
02
Drugs
budesonide
03
Conditions
microscopic colitis (MC)bile acid diarrhea (BAD)
Beyond the preview
Go deeper on 2019-002762-12.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2019-002762-12.